Richardson Financial Services’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$98.7K Hold
437
– – 0.06% 243
2026
Q2
$94.4K Hold
437
– – 0.05% 242
2026
Q1
$80.1K Hold
437
– – 0.05% 243
2025
Q4
$76.9K Hold
437
– – 0.02% 254
2025
Q3
$61.2K Hold
437
– – 0.04% 264
2025
Q2
$56.8K Hold
437
– – 0.04% 241
2025
Q1
$59.8K Hold
437
– – 0.05% 225
2024
Q4
$65.6K Hold
437
– – 0.05% 232
2024
Q3
$101K Hold
437
– – 0.06% 199
2024
Q2
$101K Hold
437
– – 0.07% 190
2024
Q1
$94.2K Hold
437
– – 0.07% 200
2023
Q4
$113K Buy
+437
New +$107K 0.1% 165

Other funds holding BIIB

Richardson Financial Services's BIIB Position: Q3 2026 in Review

Richardson Financial Services held its Biogen (BIIB) position steady in Q3 2026 at 437 shares worth $98.7K. The position accounts for 0.06% of the portfolio, ranked #243.

Richardson Financial Services first reported a position in BIIB in Q4 2023 and has held it in 12 quarters since. The position peaked at $113K in Q4 2023. 1,059 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Richardson Financial Services held 437 shares of Biogen worth $98.7K as of Q3 2026.
  • Richardson Financial Services left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.06% of Richardson Financial Services's portfolio in Q3 2026, its #243 holding.
  • Richardson Financial Services first reported a position in Biogen in Q4 2023 and has held it in 12 quarters since.
  • Richardson Financial Services's Biogen position peaked at $113K in Q4 2023.
  • 1,059 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Richardson Financial Services's 13F filing for Q3 2026, filed 30 Oct 2026.